tiprankstipranks
Zynerba Pharmaceuticals (ZYNE)
NASDAQ:ZYNE

Zynerba Pharmaceuticals (ZYNE) Stock Investors

2,375 Followers
Based on 703,242 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ZYNE
On average, investors allocate 3.14% of their portfolios to ZYNE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ZYNE

2.2%
Last 7
Days
5.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ZYNE, out of 703,242 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ZYNE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
2.33%
$0.36
Reduced
0.37%
$1.28
Increased
1.64%
$0.51
Based on the activity of 12,890 investors who made their portfolios public
The table shows changes in ZYNE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ZYNE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
4.91%
+0.14%
+2.45%
32.86B
Healthcare
Micron
5.61%
-0.64%
-0.87%
75.76B
Technology
Coherus Biosciences
2.53%
-0.12%
-4.13%
412.08M
Healthcare
Assertio Therapeutics
3.10%
-0.84%
-5.34%
232.77M
Healthcare
Nikola
6.47%
-0.09%
-0.02%
1.11B
Energy
Roku
5.12%
-0.31%
-2.33%
8.49B
Technology
AMC Entertainment
5.42%
-0.58%
-1.30%
1.96B
Consumer Cyclical
Block
4.19%
+0.10%
-0.13%
25.22B
Technology
Tilray
3.71%
-0.83%
-4.61%
1.52B
Healthcare
Blink Charging Co
4.33%
+0.16%
+2.11%
208.17M
Utilities
Based on the activity of 703,242 active portfolios
Open your Smart Portfolio

ZYNE Investor Analysis

ZYNE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
19.6%
of ZYNE holders
are under 35
Average Segment Performance
Average P/E Ratio20.30
Beta8.53
Dividend Yield13.56%
ZYNE investors between 35–55

Between 35–55

12.7%
Last 30 days
Holdings Change
56.2%
of ZYNE holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.05
Beta12.75
Dividend Yield23.61%
ZYNE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
24.3%
of ZYNE holders
are over 55
Average Segment Performance
Average P/E Ratio16.59
Beta5.76
Dividend Yield11.70%
Overview of age group and performance of ZYNE stock investors
See who invests in ZYNE according to age group and performance.

FAQ

How many retail Investors hold ZYNE?
<0.1% of TipRanks' retail investors hold ZYNE in their portfolios.
    What is ZYNE Investor Sentiment?
    ZYNE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ZYNE in the last 7 days?
      ▼ 2.2% of TipRanks' retail investors changed their holding of ZYNE in the last 7 days.
        What percentage of retail investors changed their holding of ZYNE in the last 30 days?
        ▼ 5.5% of TipRanks' retail investors changed their holding of ZYNE in the last 30 days.
          What is the average age of retail investors who hold ZYNE?
          The average age of ZYNE Holders is between 35–55.
            What other stocks have ZYNE investors also bought?
            ZYNE Investors also bought MRNA, MU, CHRS, ASRT, NKLA, ROKU, AMC, SQ, TLRY, BLNK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              OPCHOption Care Health
              LCTXLineage Therap
              CRLCharles River Labs
              CICigna
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis